DBP complete antigens (DBP–BSA and DBP–OVA) were designed and synthesized novelty.
The development of DBP monoclonal antibody with no cross-reactivity, low LOD (0.06 ng mL− 1) and IC50 (7.34 ng mL− 1)
Optimization and evaluation of indirect complete competitive enzyme immunoassay
Application of the method in detecting DBP of internal exposure among Chinese human urinary
Subjects were randomly recruited and system classified by ages, genders and educations.